MaxCyte, Inc. (MXCT): Shareholders' Equity
$171.49M
As of 2025-12-31
$158.75M
As of 2026-06-30
-12.3%
3-year compound annual growth
+38.9%
5-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $171.49M | -16.9% | 2026-03-25, Balance as of period end |
| 2024-12-31 | $206.25M | -11.2% | 2026-03-25, Balance as of period end |
| 2023-12-31 | $232.17M | -8.6% | 2025-03-11, Balance as of period end |
| 2022-12-31 | $253.97M | -3.4% | 2024-03-12, Balance as of period end |
| 2021-12-31 | $262.90M | +691.3% | 2023-03-15, Balance as of period end |
| 2020-12-31 | $33.23M | +144.3% | 2022-03-22, Balance as of period end |
| 2019-12-31 | $13.60M | n/a | 2022-03-22, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| MaxCyte, Inc. (MXCT) | 2025-12-31 | $171.49M | -16.9% |
| OmniAb, Inc. (OABI) | 2025-12-31 | $267.03M | -7.2% |
| Foxo Technologies Inc. (FOXO) | 2025-12-31 | $11.14M | +109.3% |
| NRC Health (NRC) | 2025-12-31 | $13.99M | -55.3% |
| bioAffinity Technologies, Inc. (BIAF) | 2025-12-31 | $7.28M | +179.7% |
| Absci Corp (ABSI) | 2025-12-31 | $189.45M | +5.8% |
| iSpecimen Inc. (ISPC) | 2025-12-31 | $3.09M | -6.7% |
| OneMedNet Corp (ONMD) | 2025-12-31 | -$2.96M | n/m |
| Medpace Holdings, Inc. (MEDP) | 2025-12-31 | $459.07M | -44.4% |
Compare MXCT, OABI, FOXO, NRC side by side · Screen every company in Services-Commercial Physical & Biological Research ↗